In Brief: Baxter International
This article was originally published in The Gray Sheet
Executive SummaryBaxter International: Names Peter McKee chief financial officer of its health care cost management company, which is set to be spun off later in the year. McKee, who joins Baxter immediately to help the company gear up for the spin-off, has been senior VP and CFO for Dallas-based drug distributor FoxMeyer Health Corp. since 1993...
You may also be interested in...
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.